The Osteocalcin Controversy - Chair
Presenter: Bente Langdahl, MD, PhD, DMSc (Aarhus University Hospital)
Relationship: Commercial Interest(s)
  Advisory Board Member: Amgen Inc
  Advisory Board Member: Other (fill in the blank below)
  Advisory Board Member: UCB, Gedeon-Richter
  Speaker: AstraZeneca
  Speaker: Other (fill in the blank below)
  Speaker: UCB, Gedeon-Richter, Astellas
  Grant Recipient: Amgen Inc
  Grant Recipient: Novo Nordisk

The Osteocalcin Controversy - Chair
Presenter: Roberto Civitelli, MD (Washington Univ-St Louis)
Relationship: Commercial Interest(s)
  Advisory Board Member: Ultragenyx.
  Consulting Fee: Pharmacosmos. Research Investigator
  Ultragenyx.: Ferring Pharmaceuticals, Bayer Schering Pharma.

The Osteocalcin Controversy - Reproduction and Cognitive Effects
Presenter: Andrea Isidori, PhD, MD (Sapienza University of Rome)
Relationship: Commercial Interest(s)
  Advisory Board Member: Amgen Inc, UCB.
  Consulting Fee: UCB.
  Grant Recipient: Amgen Inc, Novo Nordisk. Research Investigator

The Osteocalcin Controversy - The Clinical Dilemmas
Presenter: Ann Schwartz, PhD (University of CA-San Francisco)
No relevant financial relationships

Osteocalcin and Glucose Metabolism: What the Mouse Models Tell Us
Presenter: Fanxin Long, Ph.D. (The Children's Hospital of Philadelphia)
No relevant financial relationships